| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 06/17/2004 | WO2004032911A3 Styrylacrylonitrile compounds for inhibition of vascular endothelial growth factor |
| 06/17/2004 | WO2004029089A3 Novel angiogenesis target and uses thereof |
| 06/17/2004 | WO2004027421A3 Adp assay |
| 06/17/2004 | WO2004012651A3 Composition for heart disease, method to prepare same and uses thereof |
| 06/17/2004 | WO2004003164A3 Methods of organ regeneration |
| 06/17/2004 | WO2003106660A3 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 06/17/2004 | WO2003102138A3 Elongase genes and uses thereof |
| 06/17/2004 | WO2003071281A3 Estrogen receptor interaction with a transcription factor |
| 06/17/2004 | US20040116698 6-Substituted pyrido-pyrimidines |
| 06/17/2004 | US20040116697 Novel compounds |
| 06/17/2004 | US20040116695 2-Mercapto-4,5-diarylimidazole derivatives and the use thereof as cyclooxygenase inhibitors |
| 06/17/2004 | US20040116516 Pharmaceutical composition |
| 06/17/2004 | US20040116498 Regulations of lipids and/or bone density and compositions therefor |
| 06/17/2004 | US20040116497 Chromane derivatives, process for their preparation and their use as antitumor agents |
| 06/17/2004 | US20040116495 Compounds and methods |
| 06/17/2004 | US20040116486 Metalloproteinase inhibitors |
| 06/17/2004 | US20040116472 inhibit angiogenesis, tumor metastasis and growth, osteoporosis, Paget's disease, hypercalcemia of malignancy, retinopathy, macular degeneration, arthritis, periodontal disease, smooth muscle cell migration and viral diseases |
| 06/17/2004 | US20040116458 Chemical compounds |
| 06/17/2004 | US20040116454 Pyrazole compounds useful as protein kinase inhibitors |
| 06/17/2004 | US20040116439 Serine protease inhibitors |
| 06/17/2004 | US20040116438 Compositions for treatment of cell proliferation disorders |
| 06/17/2004 | US20040116435 Benzimidazol derivatives modulate chemokine receptors |
| 06/17/2004 | US20040116431 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 06/17/2004 | US20040116424 Aryl imidazoles and related compounds as C5a receptor modulators |
| 06/17/2004 | US20040116423 5-Aryltetrazole compounds, compositions thereof, and uses therefor |
| 06/17/2004 | US20040116416 having immunomodulating and cytokine-release-inhibiting action |
| 06/17/2004 | US20040116372 to decrease the number of cells which may accumulate in chronic inflammatory disease by enhancing apoptosis at the site of increased cell number via gene therapy |
| 06/17/2004 | US20040116357 For prophylaxis and therapy of hyperglycemia such as diabetes, diabetic complications or obesity |
| 06/17/2004 | US20040116353 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 06/17/2004 | US20040116328 Condensed imidazole derivatives |
| 06/17/2004 | US20040115261 Controlled delivery of tetracycline compounds and tetracycline derivatives |
| 06/17/2004 | US20040115199 Method for down-regulating osteoprotegerin ligand activity |
| 06/17/2004 | US20040115197 Remedies for infant chronic arthritis-relating diseases |
| 06/17/2004 | CA2508309A1 Remedy |
| 06/17/2004 | CA2507763A1 Fused 1,3-dihydro-imidazole ring compounds |
| 06/17/2004 | CA2505857A1 Novel heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators |
| 06/17/2004 | CA2485957A1 Protease inhibitor |
| 06/17/2004 | CA2481489A1 Cysteine protease inhibitor |
| 06/16/2004 | EP1428880A1 Kidney-specific urate transporter and gene thereof |
| 06/16/2004 | EP1428832A2 Peptide and O-glycan inhibitors of selectin mediated inflammation |
| 06/16/2004 | EP1428820A1 Non-imidazole alkylamines as histamine H-3-receptor ligands and their therapeutic applications |
| 06/16/2004 | EP1427857A2 Mid 4460, a human tyrosine phosphatase family member and uses therefor |
| 06/16/2004 | EP1427841A2 Nucleic acid-associated proteins |
| 06/16/2004 | EP1427755A2 Use of peptides comprising post-translational modifications in the treatment of autoimmune pathologies |
| 06/16/2004 | EP1427732A1 Spirocyclic-6,7-dihydro-5h-pyrazolo 1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 06/16/2004 | EP1427728A1 6,7-DIHYDRO-5H-PYRAZOLO 1,2-A PYRAZOL-1-ONES WHICH CONTROL INFLAMMATORY cYTOKINES |
| 06/16/2004 | EP1427727A1 Compounds which inhibit the release of inflammatory cytokines |
| 06/16/2004 | EP1427708A1 Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 06/16/2004 | EP1427707A1 Substituted indazole compounds for the treatment of inflammation |
| 06/16/2004 | EP1427706A1 Substituted pyrazolo compounds for the treatment of inflammation |
| 06/16/2004 | EP1427438A2 Inflammation modulatory compound comprising an endomorphin |
| 06/16/2004 | EP1427434A2 Anti-inflammatory agent |
| 06/16/2004 | EP1427431A2 Bioadhesive compositions and methods for enhanced mucosal drug absorption |
| 06/16/2004 | EP1427427A1 Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect |
| 06/16/2004 | EP1427418A2 Piperazinone compounds as anti-tumor and anti-cancer agents and methods of treatment |
| 06/16/2004 | EP1427412A1 Methods of treating cytokine mediated diseases |
| 06/16/2004 | EP1427410A1 Use of annellated pyrrole compounds in the treatment of articular cartilage or subchondral bone degeneration |
| 06/16/2004 | EP1427399A2 Retinoid receptor pan-antagonists for stimulating chondrogenesis |
| 06/16/2004 | EP1427289A2 Pulsatile release compositions and methods for enhanced gastrointestinal drug absorption |
| 06/16/2004 | EP1351958B1 Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation |
| 06/16/2004 | EP1268387B1 Specific salt forms of triphenylethylene derivatives as selective estrogen receptor modulators |
| 06/16/2004 | EP1244643B1 Tryptase inhibitors |
| 06/16/2004 | EP1235777B1 Vitamin d analogues |
| 06/16/2004 | EP1233772A4 Boron compounds and complexes as anti-inflammatory agents |
| 06/16/2004 | EP1194411B1 Benzoylpyridazines |
| 06/16/2004 | EP0973730B1 Calcilytic compounds |
| 06/16/2004 | EP0881908B1 Use of fibroblast growth factors to stimulate bone growth |
| 06/16/2004 | CN1505640A T cell receptor Vbeta-Dbeta-Jbeta sequence and methods for its detection |
| 06/16/2004 | CN1505630A Pyrazolo[1,5-a]pyridines and medicaments containing thereof |
| 06/16/2004 | CN1505628A Triazole compounds useful in treating diseases associated with unwanted cytokine activity |
| 06/16/2004 | CN1505627A Cyclic amp-specific phosphodiesterase inhibitors |
| 06/16/2004 | CN1505626A Novel benzylpiperidine compound |
| 06/16/2004 | CN1505625A Triazole compounds useful in treating diseases associated with unwanted cytokine activity |
| 06/16/2004 | CN1505618A Dimeric isoflavones |
| 06/16/2004 | CN1505617A Peptides as met-ap2 inhibitors |
| 06/16/2004 | CN1505613A Substituted indoles, pharmaceutical compositions containing such indoles and their use as ppar-gamma binding agents |
| 06/16/2004 | CN1505603A Substituted benzoic ac id derivatives exhibiting nf-ª—b inhibiting activity |
| 06/16/2004 | CN1505517A Method of administration of bisphosphonates by inhalation in the treatment or prevention of bone resorption and osteoporosis |
| 06/16/2004 | CN1504752A Vaughan Tristan J. |
| 06/16/2004 | CN1504479A Bone formation stimulant, synthetic method and uses thereof |
| 06/16/2004 | CN1504225A Composite medicine for prevention and cure of osteoporosis and its application |
| 06/16/2004 | CN1153770C Substitued nitrogen heterocyclic ring as inhibitors of P38 protein kinase |
| 06/16/2004 | CN1153583C Medicine for bone injury |
| 06/16/2004 | CN1153578C Medicine for treating bone fracture and osteopathy |
| 06/15/2004 | US6750360 Lipoxin compounds and their use in treating cell proliferative disorders |
| 06/15/2004 | US6750253 Aminobenzophenones as inhibitors of il-1β and tnf-α |
| 06/15/2004 | US6750249 Gradually release esculetin or its derivative in a controlled manner over a long period of time |
| 06/15/2004 | US6750248 Methods for preparing an estrogenic preparation and isolated estrogenic compounds from a plant and uses thereof |
| 06/15/2004 | US6750241 Two or more ligand moieties covalently linked together by one or more linking groups enabling binding to multiple binding sites; increased efficacy, selectivity and duration; anti-proliferative and anticarcinogenic |
| 06/15/2004 | US6750232 2-aminopyridine compounds and use thereof as drugs |
| 06/15/2004 | US6750228 Uncontrolled breakdown of connective tissue by metalloproteases is a feature of many pathological conditions |
| 06/15/2004 | US6750217 Anticancer agents; cardiovascular disorders; kinase inhibitor |
| 06/15/2004 | US6750202 Inhibitors of procollagen c-proteinase (pcp), for treating fibrosis of the liver |
| 06/15/2004 | US6749851 Applying radiation |
| 06/15/2004 | US6749832 Labelled ascorbic acid derivatives |
| 06/15/2004 | CA2329800C Protein formulations |
| 06/15/2004 | CA2313302C New metalloprotease inhibitors, the process for preparing them and the pharmaceutical compounds containing them |
| 06/15/2004 | CA2192714C Quasiturbine (qurbine) zero vibration - continuous combustion rotary engine, compressor and pump |
| 06/15/2004 | CA2088334C Fast dissolving tablet and its production |
| 06/10/2004 | WO2004048574A1 Immunoreceptor proteins |